Illustration: Shoshana Gordon/Axios
Telehealth companies need to add products, tech and services to keep up with the evolving competitive and regulatory landscape.
Case in point: Hims & Hers said over the weekend that it would no longer sell compounded versions of Novo Nordisk's Wegovy pill.
